[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dicks, 2023 - Google Patents

Biofilm formation of clostridioides difficile, toxin production and alternatives to conventional antibiotics in the treatment of cdi

Dicks, 2023

View HTML
Document ID
10572289605299378226
Author
Dicks L
Publication year
Publication venue
Microorganisms

External Links

Snippet

Clostridioides difficile is considered a nosocomial pathogen that flares up in patients exposed to antibiotic treatment. However, four out of ten patients diagnosed with C. difficile infection (CDI) acquired the infection from non-hospitalized individuals, many of whom have …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Simons et al. Bacteriocins, antimicrobial peptides from bacterial origin: overview of their biology and their impact against multidrug-resistant bacteria
Wang et al. Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era
Lade et al. Bacterial targets of antibiotics in methicillin-resistant Staphylococcus aureus
Jubeh et al. Resistance of gram-positive bacteria to current antibacterial agents and overcoming approaches
Faïs et al. Colibactin: more than a new bacterial toxin
Li et al. Vancomycin resistance in Enterococcus and Staphylococcus aureus
Martin-Verstraete et al. The regulatory networks that control Clostridium difficile toxin synthesis
Lekshmi et al. The food production environment and the development of antimicrobial resistance in human pathogens of animal origin
Mooyottu et al. Carvacrol and trans-cinnamaldehyde reduce Clostridium difficile toxin production and cytotoxicity in vitro
Pérez-Cobas et al. Colonization resistance of the gut microbiota against Clostridium difficile
Jubelin et al. Modulation of enterohaemorrhagic Escherichia coli survival and virulence in the human gastrointestinal tract
Piccioni et al. Gut microbiota and clostridium difficile: what we know and the new frontiers
Markovska et al. Clostridioides difficile, a new “superbug”
Meroni et al. Probiotics as therapeutic tools against pathogenic biofilms: have we found the perfect weapon?
Culligan et al. Advances in the microbiome: applications to Clostridium difficile infection
Dicks Biofilm formation of clostridioides difficile, toxin production and alternatives to conventional antibiotics in the treatment of cdi
Zheng et al. Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus
Chateau et al. The Bacillus anthracis cell envelope: composition, physiological role, and clinical relevance
Zucca et al. Novel avenues for Clostridium difficile infection drug discovery
Jain et al. Probiotics and their bioproducts: a promising approach for targeting methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus
Alshrari et al. The urgent threat of Clostridioides difficile infection: A glimpse of the drugs of the future, with related patents and prospects
Bucheli et al. Combined action of antibiotics and bacteriocins against vancomycin-resistant enterococci
Markantonis et al. Clostridioides difficile infection: diagnosis and treatment challenges
Pouget et al. Adaptation of Staphylococcus aureus in a medium mimicking a diabetic foot environment
Dicks How does quorum sensing of intestinal bacteria affect our health and mental status?